Lipitor Replaced with Generics

Published Online: Thursday, December 1, 2005

Lipitor, Pfizer's $2.9-billion cholesterol-lowering drug, and 3 other of the company's brand name pharmaceuticals, will be dropped from Express Scripts' preferred drug formulary and replaced by lower-cost generic alternatives, officials at the company announced. Express Scripts, which provides pharmacy benefit management (PBM) services to more than 50 million patients in North America, plans to convert many Lipitor users to Zocor, Merck's competing cholesterol drug, which will be open for generic competition next year.

Responding to the PBM's decision, officials at Pfizer announced that they will suspend rebates to Express Scripts in 2006. According to some industry analysts, the loss of Pfizer rebates could cost Express Scripts $50,000 over the short haul, but that money could be quickly recouped through the high margins available on generic drugs.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues